Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of romidepsin in treating patients who have locally
advanced or metastatic neuroendocrine tumors. Drugs used in chemotherapy, such as romidepsin,
work in different ways to stop tumor cells from dividing so they stop growing or die.